Atypical erythema multiforme related to BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine

Int J Dermatol. 2021 Nov;60(11):e466-e467. doi: 10.1111/ijd.15894. Epub 2021 Sep 2.

Authors

Cecilia Buján Bonino¹, Noelia Moreiras Arias¹, María López-Pardo Rico¹, Gabriela Pita da Veiga Seijo¹, Elena Rosón López¹, José Manuel Suárez Peñaranda², Dolores Sánchez-Aguilar Rojas¹

Affiliations

¹ Department of Dermatology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain.
² Department of Pathology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain.

No abstract available

Publication types

Letter

MeSH terms

BNT162 Vaccine
COVID-19 Vaccines
COVID-19*
Erythema Multiforme* / chemically induced
Humans
SARS-CoV-2

Substances

COVID-19 Vaccines
BNT162 Vaccine